Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cyramza
Marketing
Lilly's Cyramza wins first-line lung cancer nod
The first-line EGFR-mutated NSCLC nod puts Cyramza in direct competition against AstraZeneca's market-leading Tagrisso.
Angus Liu
Jun 1, 2020 3:31am
Lilly's Cyramza narrowly wins lung cancer backing from FDA panel
Feb 27, 2020 11:05am
Lilly touts Cyramza lung cancer data. Can it hang with Tagrisso?
Oct 7, 2019 11:24am
Lilly scores targeted liver cancer win for Cyramza
May 13, 2019 12:02pm
Lilly Oncology’s strategy? Listen to tough talk from patients
Jul 11, 2018 9:55am
Lilly, leaning on oncology for growth, loses leader Mahony
May 24, 2018 12:50pm
